Comparison between dexmedetomidine and midazolam as intranasal premedications forchildren admitted for elective surgery

dc.contributor.author	Wissam Daham Hammoud
dc.contributor.author	Dr . Aimen Hameed Latef
dc.date.accessioned	2026-01-02T11:32:21Z
dc.date.issued	2022-08-22
dc.description.abstract	The intranasal route is a reliable way to administer preanaesthetics and sedatives to children. Midazolam has been accepted as a safe and effective intranasal premedication. Intranasal dexmedetomidine, a well-tolerated and convenient treatment option, has been shown to induce a favorable anxiolysis in children
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/emrp/article/view/2076
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/77346
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/emrp/article/view/2076/1820
dc.source	Eurasian Medical Research Periodical; Vol. 11 (2022): EMRP; 57-66
dc.source	2795-7624
dc.subject	Midazolam
dc.subject	dexmedetomidine
dc.subject	intranasal
dc.subject	Premedications
dc.title	Comparison between dexmedetomidine and midazolam as intranasal premedications forchildren admitted for elective surgery
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: hammoud_2022_comparison_between_dexmedetomidine_and_m.pdf
item.page.filesection.size: 234.25 KB
item.page.filesection.format: Adobe Portable Document Format